Building biospecimen collections from patients enrolled in the NHMRC-funded NSW Inherited Cardiomyopathy Study for ongoing research.
What is the issue for NSW?
Inherited cardiomyopathies can have important health implications, often presenting in younger patients conferring a risk of heart failure and sudden cardiac death. Many aspects of care are not well understood. The NSW health system and research environment offer unique opportunities to follow patients over a long period of time to make important discoveries.
What does the research aim to do and how?
This study will aim to collect blood samples from ~3,000 individuals with an inherited cardiomyopathy who are alive and residing in NSW during 2021-2022; and to obtain permission for ongoing data collection in to the future. This will allow researchers to answer important questions about inherited cardiomyopathies, including who is at risk of serious cardiovascular outcomes and whether genomics can improve disease management.